Federal contractor profile

DETECT INC

UEI T9JGP21Q2XU3CAGE 8W7V1Company website ↗

Active

Small Business

Overview

Legal name: DETECT INC
Registered location: GUILFORD, CT, USA
Website: Company website ↗
Primary NAICS: 325413 — In-Vitro Diagnostic Substance Manufacturing
Latest award activity: Feb 19, 2025

Read company summary

DETECT INC is associated with UEI T9JGP21Q2XU3 and CAGE 8W7V1 in public federal records. AcornBids currently links 1 prime award totaling $25.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists GUILFORD, CT, USA.

At a glance

Lifetime prime obligations$25.5M

Prime awards1

Awards with future end dates1

Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: DETECT INC
UEI: T9JGP21Q2XU3
CAGE: 8W7V1
Registered address: 351 NEW WHITFIELD ST, GUILFORD, CT, 06437, USA
Registration status: Active
Primary NAICS: 325413 — In-Vitro Diagnostic Substance Manufacturing
SAM activation: Oct 28, 2025
Initial registration: Feb 16, 2021
Entity start: Jul 30, 2018
SAM updated: Oct 28, 2025
Registration expires: Oct 22, 2026
Fiscal year end: Dec 31
Place of incorporation: DE, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
75A50122C00010THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF A SECOND-GENERATION, MULTI-ANALYTE MOLECULAR SARS-COV-2 AND INFLUENZA A/B TEST THAT HAS A REDUCED TIME TO RESULT AND INCREASED…	Department of Health and Human Services	$25.5M	Jan 24, 2022	Oct 26, 2026

Explore, filter and export all awards →Subcontracts Grants & subgrants

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF A SECOND-GENERATION, MULTI-ANALYTE MOLECULAR SARS-COV-2 AND INFLUENZA A/B TEST THAT HAS A REDUCED TIME TO RESULT AND INCREASED…

Department of Health and Human Services$25.5M obligationsEnds Oct 26, 202660% recompete estimate

Registration, certifications & contacts

Registration evidence	Date
SAM updated	Oct 28, 2025
Source loaded	Sep 2, 2026
Initial registration	Feb 16, 2021
Entity start	Jul 30, 2018

Registration classifications: Small Business. These are separate from the reported certificates above.

Industry	Reported size status
325413 — In-Vitro Diagnostic Substance Manufacturing	Not reported

Contact	Role	Published contact methods	Evidence	Source date
KEITH GANTNER	Government business	Contact method not published	SAM registration	Not available
SARAI MEYER	Alternate government business	Contact method not published	SAM registration	Not available
MICHAEL BOURGEAULT	Electronic business	Contact method not published	SAM registration	Not available

Registered industries

325413 — In-Vitro Diagnostic Substance Manufacturing

Registered products and services

6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source